Follow Us:      
Career | News & Media
WHO GMP & PIC/S Approved Pharmacetical Manufacturer & Exporter

CARFILOJAS - 60 MG

carfilojas--60mg

CARFILOJAS - 60 MG

        
Category Oncology
Brand CARFILOJAS 
Ingredient Carfilzomib
Prescription Required Yes
Strength 60 mg
Package Vial
Certification WHO - GMP Certified


CARFILOJAS 60 mg  (Carfilzomib for Injection 60 mg) by Jasgur LifeScience is a high-quality oncology medicine used in the treatment of multiple myeloma in adult patients, as prescribed by healthcare professionals. Formulated to meet stringent pharmaceutical quality standards, CARFILOJAS works by inhibiting proteasomes, helping slow the growth and survival of cancer cells. The injection is administered intravenously under medical supervision and may be used alone or in combination with other anticancer therapies based on the treatment plan. Jasgur LifeScience is committed to delivering reliable, effective, and globally trusted oncology medicines to support advanced cancer care. Carfilzomib 60 mg injection in india .

GET ENQUIRY

Whatsapp Directly

Related Products - Oncology Medicine Manufacturing in India

DASABUZZ IP 50 mg

DASABUZZ IP 50 mg

View More
Palbojas 125 mg (Palbociclib 125 mg)
PALBOJAS 125 mg

PALBOJAS 125 mg

View More
BENDAJAS - 100mg
BENDAJAS - 100mg

BENDAJAS - 100mg

View More
Zolejas
ZOLEJAS  Injection 4mg

ZOLEJAS  Injection 4mg

View More


Disclaimer: The information provided on this website is for general informational purposes only and is intended exclusively for healthcare professionals, distributors, wholesalers, hospitals, clinics, pharmacies, and other authorized business entities. Jasgur Life Sciences LLP. does not provide medical advice, prescribe or recommend any medication, or promote self-medication. The use of any medicine or treatment should always be based on the advice and judgment of a qualified healthcare professional. Nothing contained on this website shall be construed as an offer, invitation, or solicitation to sell or supply any product in any jurisdiction where such sale, marketing, distribution, or import is restricted, prohibited, or requires prior regulatory approval. Products protected by valid patent rights are not offered for sale in countries where their sale would constitute patent infringement. Importers, distributors, and buyers are solely responsible for ensuring compliance with all applicable laws, regulations, patent rights, and import requirements in their respective jurisdictions.